Beximco Pharmaceuticals Limited

LSE:BXP.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

💉 Vaccines

Location

Bangladesh

Market Cap

USD 345.40 M

Share Price

USD 0.52

Avg Daily Volume

27,530

Change (1 day)

0.20%

Change (1 year)

4.49%

Change (YTD)

5.98%

Beximco Pharmaceuticals Limited Accounts Payable for the year ending August 09, 2025: N/A

Beximco Pharmaceuticals Limited Accounts Payable is NA for the year ending August 09, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Eli Lilly and Company

USD 625.65

LLY

-15.21 -2.37%

AbbVie Inc.

USD 198.05

ABBV

-0.81 -0.41%

Roche Holding AG

USD 318.77

RO.SW

-3.47 -1.08%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Abbott Laboratories

USD 134.28

ABT

+2.22 1.68%

Novartis AG

USD 116.31

NOVN.SW

+1.16 1.00%

Merck & Co., Inc.

USD 80.69

MRK

+0.32 0.40%

Amgen Inc.

USD 288.23

AMGN

+3.53 1.24%

Pfizer Inc.

USD 24.58

PFE

+0.35 1.44%

Sanofi

USD 94.22

SAN.PA

-0.08 -0.08%

CSL Limited

USD 170.04

CSL.AX

-3.16 -1.82%

GSK plc

USD 18.80

GSK.L

-0.55 -2.85%

Zoetis Inc.

USD 147.35

ZTS

-0.89 -0.60%

Regeneron Pharmaceuticals, Inc.

USD 563.00

REGN

+3.20 0.57%

Jiangsu Hengrui Medicine Co., Ltd.

USD 8.49

600276.SS

+0.02 0.26%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities